Search Results - "Borrás, Joaquín"

Prediction of Neuropsychiatric Adverse Events Associated with Long-Term Efavirenz Therapy, Using Plasma Drug Level Monitoring by Gutiérrez, Félix, Navarro, Andrés, Padilla, Sergio, Antón, Rosa, Masiá, Mar, Borrás, Joaquín, Martín-Hidalgo, Alberto

“…Background. Data on long-term central nervous system (CNS) toxicity associated with efavirenz therapy are scarce, and risk factors remain largely unknown. We…”
Get full text

Lack of awareness of systemic lupus erythematosus and its consequences in a cohort of moderate and severe patients in Spain: The LupusVoice study by Galindo Izquierdo, Maria, Borrás Blasco, Joaquín, Pérez Ortega, Silvia, Salman-Monte, Tarek Carlos, Vela-Casasempere, Paloma, Rodríguez Almaraz, Esther, Calvo-Alen, Jaime, Álvaro-Gracia Álvaro, José María, Barbado Ajo, Mͣ Julia, Rubio Renau, Raül, Galvez-Fernandez, Marta, Bahamontes-Rosa, Noemí, Sánchez-Covisa Hernández, Joaquín, Solà Marsiñach, Carlota

“…Background and objectives Systemic lupus erythematosus (SLE) is an autoimmune condition that can highly impact patients’ quality of life (QoL). However, there…”
Get full text

Correction: Patient-reported outcome measures for systemic lupus erythematosus: an expert Delphi consensus to guide implementation in routine care by Castrejón, Isabel, Cano, Laura, Cuadrado, María José, Borrás, Joaquín, Galindo, Maria, Salman-Monte, Tarek C, Amorós, Carlos, Román, Carmen San, Cabezas, Isabel, Comellas, Marta, Muñoz, Alejandro

Get full text

Patient-reported outcome measures for systemic lupus erythematosus: an expert Delphi consensus to guide implementation in routine care by Castrejón, Isabel, Cano, Laura, Cuadrado, María José, Borrás, Joaquín, Galindo, Maria, Salman-Monte, Tarek C, Amorós, Carlos, Román, Carmen San, Cabezas, Isabel, Comellas, Marta, Muñoz, Alejandro

“…Systemic lupus erythematosus (SLE) may result in great impact on patients' quality of life, social relationships, and work productivity. The use of…”
Get full text

Safety of ferric carboxymaltose immediately after infliximab administration, in a single session, in inflammatory bowel disease patients with iron deficiency: a pilot study by Cortes, Xavier, Borrás-Blasco, Joaquín, Molés, Jose Ramón, Boscá, Maia, Cortés, Ernesto

“…To obtain preliminary safety and efficacy data on intravenous (IV) administration of infliximab (IFX) and ferric carboxymaltose (FCM) to inflammatory bowel…”
Get full text

Legionella pneumophila pneumonia possibly due to ustekinumab therapy in a patient with Crohnʼs disease by Borrás-Blasco, Joaquín, Cortes, Xavier, Fernandez-Martinez, Sergio, Casterá, Elvira, Antequera, Beatriz

“…PURPOSE.A case report of Legionella pneumophila pneumonia associated with off-label use of ustekinumab in a patient with Crohnʼs disease (CD) is presented…”
Get full text

Cost-effectiveness analysis of ferric carboxymaltose versus iron sucrose for the treatment of iron deficiency anemia in patients with inflammatory bowel disease in Spain by Argüelles-Arias, Federico, Bermejo, Fernando, Borrás-Blasco, Joaquín, Domènech, Eugeni, Sicilia, Beatriz, Huguet, José M., de Arellano, Antonio Ramirez, Valentine, William J., Hunt, Barnaby

“…Background: Iron deficiency anemia (IDA) is a common complication of inflammatory bowel disease (IBD) and can result in reduced quality of life and increased…”
Get full text

Three-Dimensional Mixed-Ligand Coordination Polymers with Ferromagnetically Coupled Cyclic Tetranuclear Copper(II) Units Bonded by Weak Interactions by Balboa, Susana, Borrás, Joaquín, Brandi, Pilar, Carballo, Rosa, Castiñeiras, Alfonso, Lago, Ana B, Niclós-Gutiérrez, Juan, Real, Jose A

“…The complexes {[Cu(HGLYO)(NO3)(bpy)]·H2O}4 (1), {[Cu(HGLYO)(NO3)(phen)]·H2O}4 (2), and [Cu(HLACO)(ClO4)(phen)]4 (3) (bpy is 2,2′-bipyridine, phen is…”
Get full text

One-Dimensional Metal−Organic Framework with Unprecedented Heptanuclear Copper Units by Ferrer, Sacramento, Aznar, Elena, Lloret, Francesc, Castiñeiras, Alfonso, Liu-González, Malva, Borrás, Joaquín

“…The reaction of copper(II) sulfate, copper(II) chloride, 3,5-diacetylamino-1,2,4-triazole, and 3-acetylamino-5-amino-1,2,4-triazole in water yields green,…”
Get full text

Oxidative DNA cleavage induced by an iron(III) flavonoid complex: Synthesis, crystal structure and characterization of chlorobis(flavonolato)(methanol) iron(III) complex by El Amrani, Fátima Ben Allal, Perelló, Lourdes, Real, Jose A., González-Alvarez, Marta, Alzuet, Gloria, Borrás, Joaquín, García-Granda, Santiago, Montejo-Bernardo, José

“…A flavonol iron(III) complex, [Fe(flavonolato) 2Cl(MeOH)], has been prepared. The compound has been characterized by X-ray crystallography, spectroscopy,…”
Get full text

Coordinative Versatility of Guanazole [3,5-Diamino-1,2,4-triazole]: Synthesis, Crystal Structure, EPR, and Magnetic Properties of a Dinuclear and a Linear Trinuclear Copper(II) Complex Containing Small Bridges and Triazole Ligands by Aznar, Elena, Ferrer, Sacramento, Borrás, Joaquín, Lloret, Francesc, Liu-González, Malva, Rodríguez-Prieto, Héctor, García-Granda, Santiago

“…New complexes with guanazole (3,5‐diamino‐1,2,4‐triazole = Hdatrz), [Cu2(Hdatrz)2(μ‐OH2)(H2O)4(SO4)](SO4)·3.5H2O (1) and…”
Get full text

Acute Seizures Due to a Probable Interaction Between Valproic Acid and Meropenem by Coves-Orts, Francisco Javier, Borras-Blasco, Joaquin, Navarro-Ruiz, Andres, Murcia-Lopez, Ana, Palacios-Ortega, Francisco

“…OBJECTIVE: To report a probable interaction between meropenem and valproic acid that resulted in the development of epileptic seizures. CASE SUMMARY: A…”
Get full text

Efficient DNA Cleavage Induced by Copper(II) Complexes of Hydrolysis Derivatives of 2,4,6-Tri(2-pyridyl)-1,3,5-triazine in the Presence of Reducing Agents by Borrás, Joaquín, Alzuet, Gloria, González-Alvarez, Marta, García-Giménez, Jose L., Macías, Benigno, Liu-González, Malva

“…The reaction of 2,4,6‐tri(pyridyl)‐1,3,5‐triazine (ptz) and copper(II) salts in dmf/water (1:1) results in the hydrolysis of ptz and formation of the anions…”
Get full text

Integration of persistence in the 5P-Medicine Approach for age-related chronic diseases by Borrás-Blasco, Joaquín, Ramírez-Herráiz, Esther, Navarro-Ruiz, Andrés

“…5P medicine is defined as Personalized, Predictive, Preventive, Participatory, and Population-based. 5P medicine may be improved by including a factor that…”
Get full text

Complexes of Ni(II) and Cu(II) with ofloxacin: Crystal structure of a new Cu(II) ofloxacin complex by Macı́as, Benigno, Villa, Marı́a V., Rubio, Inmaculada, Castiñeiras, Alfonso, Borrás, Joaquı́n

“…Several coordination compounds formed between Ni(II) or Cu(II) with ofloxacin have been synthesised and characterised. According to elemental chemical analysis…”
Get full text

(1,3,4‐Oxadiazole)copper(II) Compounds: Dimensionality, Magnetism and Nuclease Activity by Gómez‐Saiz, Patricia, Gil‐García, Rubén, Maestro, Miguel A., Arnaiz, Francisco J., Lezama, Luis, Rojo, Teófilo, Pizarro, José Luis, Arriortúa, María Isabel, González‐Álvarez, Marta, Borrás, Joaquín, Diez‐Gómez, Virginia, García‐Tojal, Javier

“…The work presented here describes the synthesis of new copper(II) complexes derived from 2‐amino‐5‐(pyridin‐2‐yl)‐1,3,4‐oxadiazole (L1) and…”
Get full text

Syntheses, crystal structures, and oxidative DNA cleavage of some Cu(II) complexes of 5-amino-3-pyridin-2-yl-1,2,4-triazole by Ferrer, Sacramento, Ballesteros, Rafael, Sambartolomé, Ana, González, Marta, Alzuet, Gloria, Borrás, Joaquı́n, Liu, Malva

“…Three new monomeric Cu(II) complexes of 5-amino-3-pyridin-2-yl-1,2,4-triazole (Hapt), [Cu(Hapt)(H 2O) 2(SO 4)] ( 1), [Cu(Hapt) 2(H 2O)(NO 3)](NO 3) ( 2), and…”
Get full text

Oxidative DNA damage of mixed copper(II) complexes with sulfonamides and 1,10-phenanthroline: Crystal structure of [Cu( N-quinolin-8-yl- p-toluenesulfonamidate) 2(1,10-phenanthroline)] by Macı́as, Benigno, Garcı́a, Isabel, Villa, Marı́a V., Borrás, Joaquı́n, González-Álvarez, Marta, Castiñeiras, Alfonso

“…Mixed coordination compounds of Cu(II) with sulfonamides and 1,10-phenanthroline as ligands have been prepared and characterised. Single crystal structural…”
Get full text

Biosimilars and access to biologic therapy in immune-mediated diseases by Vázquez-Sánchez, Rocío, Navarro-Dávila, Marco, Herráiz, Esther Ramírez, Merino-Bohórquez, Vicente, Borrás-Blasco, Joaquín, Onteniente-González, Alberto, Iglesias-Lambarri, Ana, Negro-Vega, Eva

“…The rise of biologic agents has been a major breakthrough in treating immune-mediated inflammatory diseases (IMIDs). However, their high cost underscores the…”
Get more information

Six months multicentre pilot open label single‐arm study to evaluate patient experience, acceptability and satisfaction of switching certolizumab pegol from a prefilled syringe or autoinjection pen to an AVA® e‐Device in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis patients by Borrás‐Blasco, Joaquin, Vicente‐Escrig, Esther, Rodríguez‐Lucena, Francisco José, García‐Monsalve, Ana, Arroyo‐Domingo, Elena, Ferrando‐Piqueres, Raul, Casterá, Elvira, Navarro‐Ruiz, Andrés

“…What Is Known and Objective The study aimed to assess acceptability and patient experience of Certolizumab (CZP) self‐injection with AVA® and clarify patient…”
Get full text